MAPT and Alzheimer disease: Women demonstrate a higher lifetime risk of developing AD, show faster rates of cognitive decline, and exhibit greater tau burden and cortical atrophy (Altmann et al., 2014; Buckley et al., 2019; Oveisgharan et al., 2018).